Specification of background dopaminergic synaptic activity in disorders of consciousness following severe traumatic brain injury
严重创伤性脑损伤后意识障碍背景多巴胺能突触活动的规范
基本信息
- 批准号:9066823
- 负责人:
- 金额:$ 21.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmphetaminesAnabolismAnteriorArousalBehaviorBindingBiologicalBiological MarkersBiological PreservationBrain InjuriesBrain regionChronicCognitiveConsciousConsciousness DisordersControl GroupsDataDeafferentation procedureDevelopmentDextroamphetamineDiagnosisDiagnostic ProcedureDopamineDopamine ReceptorElectric StimulationEnzymesEvaluationExhibitsFailureFocal Brain InjuriesFunctional disorderFutureGoalsHealthInjuryKnowledgeLigandsMeasurementMeasuresMetabolicMetabolismMethodologyMinimally Conscious StatesNeuronsOutcomePathway interactionsPatientsPatternPopulationPositron-Emission TomographyPremedicationProcessProsencephalonRacloprideRecoveryRegulationResearchRestRoleSecondary toSourceStagingStructureSynapsesSynaptic CleftSystemTBI PatientsTechniquesTestingThalamic structureTherapeutic InterventionTraumatic Brain InjuryTyrosine 3-MonooxygenaseWorkcognitive functioncostdisabilityglucose metabolismimprovedmotor controlnerve supplyneuron lossneuroregulationneurotransmitter releasenew therapeutic targetnovelpatient populationpostsynapticpostsynaptic neuronspresynapticreceptorresearch studyresponsereuptakesocialtreatment strategyvolunteer
项目摘要
DESCRIPTION (provided by applicant): Studies in patients with disorders of consciousness (DOC) after severe brain injury implicate dysfunction of the anterior forebrain mesocircuit dysfunction a key underlying mechanism. The anterior forebrain metabolism in DOC is markedly downregulated across brain regions underpinning highly elaborated cognitive behaviors demonstrating a collapse of the level of synaptic background activity required for consistent goal-directed behavior and arousal regulation. Since dopamine levels are one of the primary controllers of the level of synaptic background activity within these forebrain structures, we propose to investigate the specific contribution of presynaptic and postsynaptic dopamine function in posttraumatic DOC. The aim of the present study is to measure the expression of D2/D3 receptors in the main dopaminergic pathways using [11C]raclopride-PET at rest and following a short pharmacological challenge with dextroamphetamine and dextroamphetamine + L-DOPA. Using this novel technique in DOC we characterized in 2 patients in chronic minimally conscious state a presynaptic deficiency to synthesize and/or release dopamine at rest, and a failure to increase the dopamine level at the synaptic cleft following stimulation with dextroamphetamine. Both phenomena were unseen in a control group of 8 normal volunteers. In addition, both subjects showed a selective postsynaptic deficit in the central thalamus, the core hub structure of the anterior forebrain mesocircuit. It is unknown whether this pattern presynaptic and postsynaptic dopaminergic failure is specific for these 2 patient subjects or is more generally seen across the population of subjects with DOC. Moreover, when identified presynaptic deficits as found in these subjects may be secondary to a failure of biosynthesis of dopamine and therefore in principle reversible by providing the main biological substrate of the synthesis process. We therefore propose to investigate patients with posttraumatic DOC using [11C]raclopride-PET at rest and following short pharmacological challenges aimed at increasing dopamine release and dopamine biosynthesis.
描述(由申请人提供):对严重脑损伤后意识障碍(DOC)患者的研究表明,前脑中间回路功能障碍是关键的潜在机制。 DOC 中前脑代谢在支撑高度复杂的认知行为的大脑区域中显着下调,表明一致的目标导向行为和唤醒调节所需的突触背景活动水平崩溃。由于多巴胺水平是这些前脑结构内突触背景活动水平的主要控制器之一,因此我们建议研究突触前和突触后多巴胺功能在创伤后 DOC 中的具体贡献。本研究的目的是使用[11C]雷氯必利-PET在休息时以及在右旋苯丙胺和右旋苯丙胺+L-DOPA的短暂药理挑战后测量主要多巴胺能通路中D2/D3受体的表达。在 DOC 中使用这项新技术,我们对 2 名处于慢性最低意识状态的患者进行了表征,他们在休息时合成和/或释放多巴胺的突触前缺陷,并且在用右旋苯丙胺刺激后未能增加突触间隙的多巴胺水平。这两种现象在由 8 名正常志愿者组成的对照组中均未出现。此外,两名受试者的中央丘脑(前前脑中枢回路的核心枢纽结构)均表现出选择性突触后缺陷。目前尚不清楚这种突触前和突触后多巴胺能衰竭模式是否是这 2 名患者受试者特有的,还是在 DOC 受试者群体中更常见。此外,当在这些受试者中发现的突触前缺陷被识别时,可能是继发于多巴胺生物合成失败的,因此原则上通过提供合成过程的主要生物底物是可逆的。因此,我们建议在休息时使用[11C]雷氯必利-PET 来研究创伤后 DOC 患者,并在短期药物挑战后进行旨在增加多巴胺释放和多巴胺生物合成的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Esteban Andres Fridman其他文献
Esteban Andres Fridman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Esteban Andres Fridman', 18)}}的其他基金
Evaluation of pharmacologically-induced changes in excitatory glutamatergic neurotransmission of severe TBI patients
药理学诱导的严重 TBI 患者兴奋性谷氨酸能神经传递变化的评估
- 批准号:
9979372 - 财政年份:2020
- 资助金额:
$ 21.19万 - 项目类别:
相似海外基金
Relationship between neurotoxicity and the chemical structures of amphetamines
安非他明的神经毒性与化学结构的关系
- 批准号:
25860103 - 财政年份:2013
- 资助金额:
$ 21.19万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for protein expression in amphetamines treated mouse heart : Challenge to the diagnosis for the sudden death of amphetamines abusers
寻找安非他明治疗小鼠心脏中的蛋白质表达:对安非他明滥用者猝死诊断的挑战
- 批准号:
22659138 - 财政年份:2010
- 资助金额:
$ 21.19万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
- 批准号:
8312648 - 财政年份:2010
- 资助金额:
$ 21.19万 - 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
- 批准号:
8531900 - 财政年份:2010
- 资助金额:
$ 21.19万 - 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
- 批准号:
8715749 - 财政年份:2010
- 资助金额:
$ 21.19万 - 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
- 批准号:
8144930 - 财政年份:2010
- 资助金额:
$ 21.19万 - 项目类别:
Translational Genetics and Dopamine Signaling in Sensitivity to Amphetamines
安非他明敏感性中的转化遗传学和多巴胺信号传导
- 批准号:
7675601 - 财政年份:2009
- 资助金额:
$ 21.19万 - 项目类别:
Simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates and interaction in the rat
大鼠体内麻黄碱、安非他明、可卡因、可卡因代谢物和阿片类药物的同时测定及其相互作用
- 批准号:
17590585 - 财政年份:2005
- 资助金额:
$ 21.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study for practical use of two chiral analyses of amphetamines by gas chromatography-mass spectrometry
气相色谱-质谱法对苯丙胺两种手性分析的实用化研究
- 批准号:
17590588 - 财政年份:2005
- 资助金额:
$ 21.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
3,4-亚甲二氧基安非他明的临床药理学
- 批准号:
6870119 - 财政年份:2004
- 资助金额:
$ 21.19万 - 项目类别:














{{item.name}}会员




